Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarker evaluation after cognitive behavioral therapy or fluoxetine in university students with major depressive disorder
RBR-3npbf8Phase 4Recruiting
- Sponsor
- Universidade Federal do Rio Grande do Norte
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluoxetine in major depressive disorder (MDD), sponsored by Universidade Federal do Rio Grande do Norte. Started Mar 2018; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on RBR-3npbf8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3npbf8.